bpc-157 fda approval status not approved warning BPC 157 Banned: Key Facts on the Latest Decision Regulatory Alert: The Legal Status
Description
For the BPC-157 TB-500 regulatory status FDA WADA 2026, TB-500 is WADA-prohibited while BPC-157 is not currently on the WADA prohibited list but both remain research-only compounds without FDA approval

Selank immune mechanisms Research on selank demonstrates several mechanisms relevant to lupus
That is by design: the protocol treats them as a single recovery unit rather than two separate injection schedules

Research suggests this coordinated signaling can produce more consistent GH pulses, enhance the precision of GH-related assays, and provide a broader view of metabolic, lipolytic, and regenerative mechanisms than either compound individually